Hadlima

Active Ingredient(s): Adalimumab-bwwd
FDA Approved: * July 23, 2019
Pharm Company: * SAMSUNG BIOEPIS CO LTD
Category: Immunosuppressive

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Hadlima Overview

Adalimumab, sold under the brand name Humira among others, is a medication used to treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, psoriasis, hidradenitis suppurativa, uveitis, and juvenile idiopathic arthritis.[1][2] Use is generally only recommended in people who have not responded to other treatments.[2] It is used by injection under the skin.[1] Common side effects...

Read more Hadlima Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Adalimumab

Recent Hadlima Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Other drugs which contain Adalimumab-bwwd or a similar ingredient: (9 results)

• ADALIMUMAB
• ADALIMUMAB-ADAZ
• ADALIMUMAB-ADBM
• ADALIMUMAB-ATTO
• ADALIMUMAB-BWWD
• AMJEVITA Adalimumab-atto
• CYLTEZO Adalimumab-adbm
• HUMIRA Adalimumab66 discussions
• HYRIMOZ Adalimumab-adaz